In our research, we have, for the first time, identified a positive association between serum FGF-21 levels and IMT in obese individuals experiencing early carbohydrate metabolism disorders, specifically prediabetes and newly diagnosed diabetes. Here, FGF21 is linked to carbohydrate metabolism disease.